Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease
Daisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 14
Open Access | Times Cited: 16

Showing 16 citing articles:

MAFLD: Exploring the Systemic Effects Beyond Liver.
Utkarsh Dayal, Ujjwal Soni, Sourav Bansal, et al.
Journal of Community Hospital Internal Medicine Perspectives (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease
Niki Katsiki, Genovefa Kolovou, Michal Vráblík
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101506-101506
Open Access | Times Cited: 33
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
Mohamad Jamalinia, Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 5
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Clinical and Experimental Hypertension (2025) Vol. 47, Iss. 1
Open Access
Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome”
Suleiman Al Ashi, Ali A. Rizvi, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 5
Open Access
Nonalcoholic fatty liver disease and chronic kidney disease: random connections or two manifestations of metabolic syndrome?
Н. С. Карпунина, О. В. Хлынова
Experimental and Clinical Gastroenterology (2025), Iss. 8, pp. 123-130
Closed Access
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification
Kamran Bagheri Lankarani, Mohamad Jamalinia, Fatemeh Zare, et al.
Advances in Therapy (2025)
Closed Access
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
Marios Zisis, Maria Chondrogianni, Θεόδωρος Ανδρουτσάκος, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 324-324
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period
Kazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.
Hepatology Research (2024)
Open Access | Times Cited: 3
Natural products: A potential immunomodulators against inflammatory-related diseases
Telukuntla Sai Priya, Vaikundamoorthy Ramalingam, Katragadda Suresh Babu
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2821-2859
Closed Access | Times Cited: 2
Association between non-alcoholic fatty liver disease and the risk of pulmonary nodules in patients with intestinal polyps
Bing Wu, Junpei Zhang, Ying Chen, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 6, pp. 3990-3999
Open Access | Times Cited: 1
Epicardial and liver fat implications in albuminuria: a retrospective study
Carolina M. Perdomo, Nerea Martín‐Calvo, Ana Ezponda, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Correlation of serum cotinine with fatty liver index in adults: data from the NHANES March 2017 and 2018
Guangwen Chen, Nan Chen, Lijian Liu, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The impact of renal tubulointerstitial dysfunction on the early and long-term prognosis in chronic heart failure patients with preserved left ventricular ejection fraction
В. В. Сыволап, В. А. Лысенко, M. O. Svitlyi
Pathologia (2024) Vol. 21, Iss. 1, pp. 5-13
Open Access
Phase I clinical trial of the feasibility and safety of direct peritoneal resuscitation in liver transplantation
Iván E. Rodrı́guez, Zachary Asher, Katherine Klingenberg, et al.
The American Journal of Surgery (2024) Vol. 238, pp. 115815-115815
Closed Access
Page 1

Scroll to top